Showing results (21-30 of 58) with videos related to
Sort By:
Pageof 6
Anaerobe|July 21, 2026
Quality of Life among Patients with Community-Onset Clostridioides difficile Infection Treated in the Outpatient SettingMark A Schmidt, Jennifer L Kuntz, Elizabeth Shuster, et al.Pain Medicine (Malden, Mass.)|February 22, 2021
"We Need to Taper." Interviews with Clinicians and Pharmacists About Use of a Pharmacy-Led Opioid Tapering ProgramAlison J Firemark, Jennifer L Schneider, Jennifer L Kuntz, et al.BMC Public Health|February 17, 2019
The Health and economic effects of light rail lines: design, methods, and protocol for a natural experimentLawrence D Frank, Jennifer L Kuntz, James E Chapman, et al.Open Forum Infectious Diseases|January 22, 2024
Burden of Medically Attended Diarrhea and Outpatient Clostridioides difficile Infection Among Persons in 2 Large Integrated Healthcare Settings, 2016-2021Sara Y Tartof, Mark A Schmidt, Richard Contreras, et al.Journal of the American Pharmacists Association : Japha|January 24, 2021
Factors associated with opioid-tapering success: A mixed methods studyJennifer L Kuntz, John F Dickerson, Jennifer L Schneider, et al.The Permanente Journal|November 16, 2020
A Pharmacist-Led Program to Taper Opioid Use at Kaiser Permanente Northwest: Rationale, Design, and EvaluationJennifer L Kuntz, Jennifer L Schneider, Alison J Firemark, et al.MMWR. Morbidity and Mortality Weekly Report|April 3, 2025
Epidemiology of Symptomatic Human Metapneumovirus Infection in the CASCADIA Community-Based Cohort - Oregon and Washington, 2022-2024Mila Shakya, Helen Y Chu, Janet A Englund, et al.Journal of General Internal Medicine|February 16, 2023
Association Between Diabetes Severity and Risks of COVID-19 Infection and OutcomesJames S Floyd, Rod L Walker, Jennifer L Kuntz, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 16, 2024
The relationship between anticholinergic burden and frailty in the year preceding a diagnosis of dementia with Lewy bodiesKathryn A Wyman-Chick, Matthew J Barrett, Michael J Miller, et al.Pharmacoepidemiology and Drug Safety|March 14, 2018
Evaluation of the US Food and Drug Administration sentinel analysis tools in confirming previously observed drug-outcome associations: The case of clindamycin and Clostridium difficile infectionRyan M Carnahan, Jennifer L Kuntz, Shirley V Wang, et al.Pageof 6